THREE YEARS OF ENTECAVIR (ETV) RE-TREATMENT OF HBEAG(-) ETV PATIENTS WHO PREVIOUSLY DISCONTINUED ETV TREATMENT: RESULTS FROM STUDY ETV-901

被引：0
|
作者：
Shouval, Daniel [1 ]
Lai, Ching-Lung [2 ]
Chang, Ting-Tsung [3 ]
Gadano, Adrian [4 ]
Wu, Shun-Sheng [5 ]
Halota, Waldemar [6 ]
Sievert, William [7 ]
Tsai, Naoky C. S. C. [8 ]
Zhang, Hui [9 ]
Iloeje, Uchenna [9 ]
机构：
[1] Hadassah Med Org, Liver Unit, Jerusalem, Israel
[2] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan
[4] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[5] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan
[6] Klin Chorob Zakaznych AM, Bydgoszcz, Poland
[7] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[8] Univ Hawaii, Honolulu, HI 96822 USA
[9] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
927
引用
收藏
页码：722A / 723A
页数：2
相关论文
共 50 条
  • [41] COMPLETE VIRAL SUPPRESSION (CVS) BY ENTECAVIR (ETV) IN PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV): INTERIM REPORT FOR A MULTICENTER STUDY
    Nguyen, Mindie H.
    Trinh, Huy N.
    Do, Son T.
    Tran, Phung L.
    Nguyen, Thuan
    Nguyen, Khanh
    Nguyen, Huy A.
    Nguyen, Nghia H.
    Garcia, Ruel T.
    HEPATOLOGY, 2010, 52 (04) : 510A - 511A
  • [42] Three-years of continuous treatment with entecavir results in high proportions of Chinese nucleoside-naive patients with undetectable HBV DNA: Results from studies ETV-023 and -050
    Yao, G. B.
    Xu, D. Z.
    Ren, H.
    Zhou, X. Q.
    Jia, J. D.
    Wang, Y. M.
    Chen, C. W.
    Liu, J.
    Xu, D.
    Llamoso, C.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S267
  • [43] Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)
    Yurdaydin, C.
    Sollano, J.
    Hadziyannis, S.
    Kaymakoglu, S.
    Sherman, M.
    Brett-Smith, H.
    Vaughan, J.
    Hindes, R. G.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S36 - S36
  • [44] Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)
    Yurdaydin, C.
    Sollano, J.
    Hadziyannis, S.
    Kaymakoglu, S.
    Sherman, M.
    Brett-Smith, H.
    Vaughan, J.
    Hindes, R.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S55 - S55
  • [45] Entecavir results in continued virologic and biochemical improvement and HBeAg Seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)
    Sherman, Morris
    Martin, Paul
    Lee, William M.
    Yurdaydin, Cihan
    Sollano, Jose D.
    Vaughan, James
    Hindes, Robert G.
    GASTROENTEROLOGY, 2006, 130 (04) : A765 - A765
  • [46] Three-years of continuous treatment with entecavir results in high proportions of Chinese nucleoside-naive patients with undetectable HBV DNA: Results from studies ETV-023 and-050
    Yao, Guang-Bi
    Xu, Dao-Zhen
    Ren, Hong
    Zhou, Xia-Qiu
    Jia, Ji-Dong
    Wang, Yu-Ming
    Chen, Cheng-Wei
    Liu, Jessica
    Xu, Dong
    Llamoso, Cyril
    GASTROENTEROLOGY, 2008, 134 (04) : A811 - A812
  • [47] Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis B
    Yurdaydin, C.
    Senturk, H.
    Boron-Kaczmarska, A.
    Raptopoulou-Gigi, M.
    Batur, Y.
    Goodman, Z.
    Vaughan, J.
    Brett-Smith, H.
    Hindes, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S190 - S191
  • [48] LONG-TERM ENTECAVIR THERAPY RESULTS IN REVERSAL OF FIBROSIS/CIRRHOSIS AND CONTINUED HISTOLOGIC IMPROVEMENT IN PATIENTS WITH HBEAG(+) AND (-) CHRONIC HEPATITIS B: RESULTS FROM STUDIES ETV-022,-027 AND-901
    Liaw, Yun-Fan
    Chang, Ting-Tsung
    Wu, Shun-Sheng
    Schiff, Eugene R.
    Han, Kwong-Hyub
    Lai, Ching-Lung
    Safadi, Rifoot
    Lee, Samuel S.
    Holota, Waldemar
    Goodman, Zachary D.
    Zhang, Hui
    Hindes, Robert
    Iloeje, Uchenno
    Beebe, Suzanne
    Kreter, Bruce
    HEPATOLOGY, 2008, 48 (04) : 706A - 706A
  • [49] Outcomes of Entecavir (Etv) and Tenofovir (Tdf) combination therapy in chronic hep-B patients with previous treatment failure
    Gill, M.
    Mehmood, N.
    Salman, F.
    Anwar, N.
    Gill, U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 164 - 165
  • [50] OUTCOMES OF ENTECAVIR (ETV) AND TENOFOVIR (TDF) COMBINATION THERAPY IN CHRONIC HEP-B PATIENTS WITH PREVIOUS TREATMENT FAILURE
    Gill, M.
    Gill, U.
    Anwar, N.
    Salman, F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S201 - S201
12345